BCMU
BSX icon

BlueCrest Capital Management (UK)’s Boston Scientific BSX Stock Holding History

BlueCrest Capital Management (UK)’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-379,968
Closed -$5.14M – 583
2014
Q1 		$5.14M Buy
+379,968
New +$4.99M 0.29% 87

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlueCrest Capital Management (UK)'s BSX Position: Q2 2014 in Review

BlueCrest Capital Management (UK) sold out of Boston Scientific (BSX) in Q2 2014, closing a stake of 379,968 shares — an estimated $5.14M sold.

BlueCrest Capital Management (UK) first reported a position in BSX in Q1 2014 and held it in 1 quarter. The position peaked at $5.14M in Q1 2014. 457 funds tracked by Wall St. Rank hold BSX as of Q2 2014.

  • BlueCrest Capital Management (UK) reported no remaining Boston Scientific position as of Q2 2014 after selling out during the quarter.
  • BlueCrest Capital Management (UK) sold 379,968 Boston Scientific shares in Q2 2014, an estimated $5.14M.
  • BlueCrest Capital Management (UK) first reported a position in Boston Scientific in Q1 2014 and held it in 1 quarter.
  • BlueCrest Capital Management (UK)'s Boston Scientific position peaked at $5.14M in Q1 2014.
  • 457 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2014.

Based on BlueCrest Capital Management (UK)'s 13F filing for Q2 2014, filed 15 Aug 2014.